The Pharma Data

SEPTEMBER 18, 2020

BioNTech acquires Novartis GMP manufacturing site to expand Covid-19 vaccine production. BioNTech has agreed to buy a Novartis manufacturing facility in Marbury, Germany, to expand its Covid-19 vaccine production capacity by up to 750 million doses per year, or more than 60 million doses per month, once fully operational.

Vaccine 52

Vaccine Long-Term Care Facilities Clinical Supply Laboratories 52

The Pharma Data

APRIL 14, 2021

There are no available data on the presence of bamlanivimab or etesevimab in human or animal milk, the effects on the breastfed infant, or the effects on milk production. A Phase 3 study of bamlanivimab alone or bamlanivimab and etesevimab together in residents and staff at long-term care facilities (BLAZE-2, NCT04497987 ) is also ongoing.

Government 52

Government Hospitals Long-Term Care Facilities Treatment 52

The Pharma Data

OCTOBER 28, 2020

government to purchase up to an additional 650,000 vials through June 30, 2021, under the same terms as the base agreement and subject to agreement from Lilly, product availability and the medical need in the U.S. The initial agreement is for delivery over the two months following an EUA and also provides the option for the U.S.

Government 40

Government Long-Term Care Facilities Hospitals Therapies 40

The Pharma Data

DECEMBER 10, 2020

A national vaccination campaign will be no easy task, with challenges that include ramping up production to tens of millions of doses, shipping them in specially designed boxes packed with dry ice to keep them ultracold and vaccinating people in every corner of the country, the Washington Post reported.

Vaccine 52

Vaccine FDA Long-Term Care Facilities Hospitals 52

The Pharma Data

DECEMBER 2, 2020

The recommendation from the Advisory Committee on Immunization Practice (ACIP), if heeded, will steer the initial short supply of vaccines to about 21 million health care personnel and 3 million Americans working or living in long-term care facilities. percent effective, the Times said.

Vaccine 40

Vaccine Long-Term Care Facilities Hospitals Nurses 40

The Pharma Data

NOVEMBER 9, 2020

government has purchased 300,000 doses of bamlanivimab and committed that Americans will have no out-of-pocket costs for the medicine, although healthcare facilities may charge a fee for the product’s administration. For media resources, including product images and fact sheets, please click here. About bamlanivimab .

Treatment 52

Treatment FDA Hospitals Long-Term Care Facilities 52

The Pharma Data

APRIL 16, 2021

For media resources, including product images and fact sheets, please click here. There are no available data on the presence of bamlanivimab or etesevimab in human or animal milk, the effects on the breastfed infant, or the effects on milk production. Important Information about bamlanivimab and etesevimab together. Breastfeeding.

Treatment 52

Treatment Hospitals Long-Term Care Facilities Virus 52

The Pharma Data

MARCH 5, 2021

Eli Lilly and Company (NYSE: LLY) announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive scientific opinion for bamlanivimab alone and bamlanivimab administered together with etesevimab. Breastfeeding. About bamlanivimab.

Treatment 40

Treatment Hospitals Long-Term Care Facilities Therapies 40

The Pharma Data

MAY 4, 2021

Breastfeeding There are no available data on the presence of bamlanivimab or etesevimab in human or animal milk, the effects on the breastfed infant, or the effects on milk production. However, as with any pharmaceutical product, there are substantial risks and uncertainties in the process of research, development and commercialization.

Therapies 52

Therapies Hospitals Treatment FDA Approval 52

The Pharma Data

JANUARY 26, 2021

Breastfeeding There are no available data on the presence of bamlanivimab in human or animal milk, the effects on the breastfed infant, or the effects on milk production. A Phase 3 study of bamlanivimab alone or bamlanivimab and etesevimab together in residents and staff at long-term care facilities (BLAZE-2, NCT04497987) is also ongoing.

Hospitals 52

Hospitals Treatment Trials Long-Term Care Facilities 52

The Pharma Data

MARCH 11, 2021

Food and Drug Administration (FDA) and a positive scientific opinion by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP). For media resources, including product images and fact sheets, please click here. Breastfeeding. About bamlanivimab.

Hospitals 40

Hospitals Trials Long-Term Care Facilities Treatment 40

The Pharma Data

SEPTEMBER 6, 2021

To complement vaccination efforts, it is also crucial to continue applying measures such as physical distancing, hand and respiratory hygiene, and using face masks where needed, in particular in high-risk settings such as long-term care facilities or hospital wards with patients at risk of severe COVID-19.

Long-Term Care Facilities 52

Long-Term Care Facilities Vaccine Immune Response Virus 52

The Pharma Data

DECEMBER 31, 2020

According to the Times , he said that health care facilities are still learning how to store the vaccines at super-low temperatures, and many states are setting aside doses for use at long-term care facilities, an effort that’s expected to take several months. Speaking Tuesday in Wilmington, Del.,

Vaccine 52

Vaccine Long-Term Care Facilities Virus Hospitals 52